10/30/2024
6:33 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:06 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:08 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:54 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:28 PM | Summit Therapeutics (Filer)
| Form S-3ASR | |
09/13/2024
6:29 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:25 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
4:54 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:40 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:26 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:29 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:49 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:23 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:14 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:37 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:20 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:16 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
3:27 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:14 PM | Summit Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/17/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
1:03 PM | Summit Therapeutics (Filer)
| Form DEFA14A | |
06/03/2024
5:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
3:48 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:35 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:03 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:48 AM | Summit Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
7:45 AM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:11 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
8:21 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
8:19 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
3:35 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:52 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
4:43 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:47 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:42 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:27 PM | Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:28 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:36 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
02/27/2024
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT | |
02/20/2024
6:55 AM | Summit Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/20/2024
7:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:32 AM | Summit Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:35 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/08/2024
3:08 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:19 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:24 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:16 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:11 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:49 PM | Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free SMMT Stock Alerts